Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0678
+0.00611 (9.90%)
At close: Sep 25, 2026
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $4.33 million as of September 25, 2026. Its market cap has increased by 516.34% in one year.
Market Cap
4.33M
Enterprise Value
32.04M
Revenue
15.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
ChartMarket Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 4.33M, a decrease of -98.77%. That is a compound annual growth rate of -45.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.33M | 421.52% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 7.05M |
| Reviva Pharmaceuticals Holdings | 6.92M |
| LianMedical | 6.44M |
| America Great Health | 6.35M |
| Orgenesis | 5.78M |
| TRON Group | 5.52M |
| Institute of Biomedical Research | 5.50M |
| Zenith Capital | 4.83M |